226 related articles for article (PubMed ID: 32812032)
1. WGCNA reveals key gene modules regulated by the combined treatment of colon cancer with PHY906 and CPT11.
Xing S; Wang Y; Hu K; Wang F; Sun T; Li Q
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32812032
[TBL] [Abstract][Full Text] [Related]
2. Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment.
Wang E; Bussom S; Chen J; Quinn C; Bedognetti D; Lam W; Guan F; Jiang Z; Mark Y; Zhao Y; Stroncek DF; White J; Marincola FM; Cheng YC
BMC Med Genomics; 2011 May; 4():38. PubMed ID: 21569348
[TBL] [Abstract][Full Text] [Related]
3. A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer.
Kummar S; Copur MS; Rose M; Wadler S; Stephenson J; O'Rourke M; Brenckman W; Tilton R; Liu SH; Jiang Z; Su T; Cheng YC; Chu E
Clin Colorectal Cancer; 2011 Jun; 10(2):85-96. PubMed ID: 21859559
[TBL] [Abstract][Full Text] [Related]
4. The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018).
Lam W; Jiang Z; Guan F; Hu R; Liu SH; Chu E; Cheng YC
BMC Complement Altern Med; 2014 Dec; 14():490. PubMed ID: 25510341
[TBL] [Abstract][Full Text] [Related]
5. Significance of aldo-keto reductase 1C3 and ATP-binding cassette transporter B1 in gain of irinotecan resistance in colon cancer cells.
Matsunaga T; Okumura N; Saito H; Morikawa Y; Suenami K; Hisamatsu A; Endo S; Ikari A
Chem Biol Interact; 2020 Dec; 332():109295. PubMed ID: 33096057
[TBL] [Abstract][Full Text] [Related]
6. A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX model.
Kim J; Kim HY; Hong S; Shin S; Kim YA; Kim NS; Bang OS
Biomed Pharmacother; 2019 Aug; 116():108987. PubMed ID: 31112870
[TBL] [Abstract][Full Text] [Related]
7. The Significant Pathways and Genes Underlying the Colon Cancer Treatment by the Traditional Chinese Medicine PHY906.
Su Z; Zhou C; Qin S; Jia E; Wu Z
Evid Based Complement Alternat Med; 2017; 2017():8753815. PubMed ID: 28588641
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of location-specific hub genes related to the pathogenesis of colon cancer.
Shi C; Ding K; Li KZ; Long L; Li JL; Hu BL
Med Oncol; 2020 Aug; 37(9):77. PubMed ID: 32743717
[TBL] [Abstract][Full Text] [Related]
9. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
Su P; Yang Y; Wang G; Chen X; Ju Y
Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
[TBL] [Abstract][Full Text] [Related]
10. Colon cancer recurrence‑associated genes revealed by WGCNA co‑expression network analysis.
Zhai X; Xue Q; Liu Q; Guo Y; Chen Z
Mol Med Rep; 2017 Nov; 16(5):6499-6505. PubMed ID: 28901407
[TBL] [Abstract][Full Text] [Related]
11. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity.
Lam W; Bussom S; Guan F; Jiang Z; Zhang W; Gullen EA; Liu SH; Cheng YC
Sci Transl Med; 2010 Aug; 2(45):45ra59. PubMed ID: 20720216
[TBL] [Abstract][Full Text] [Related]
12. Screening prognostic genes related to leucovorin, fluorouracil, and irinotecan treatment sensitivity by performing co-expression network analysis for colon cancer.
Wu P; Pan X; Lu K; Gu N
Front Genet; 2022; 13():928356. PubMed ID: 36523769
[No Abstract] [Full Text] [Related]
13. Identification of Prognostic Genes for Colon Cancer through Gene Co-expression Network Analysis.
Wang DW; Yang ZS; Xu J; Yang LJ; Yang TC; Wang HQ; Feng MH; Su F
Curr Med Sci; 2021 Oct; 41(5):1012-1022. PubMed ID: 34542829
[TBL] [Abstract][Full Text] [Related]
14. Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis.
Wang H; Liu J; Li J; Zang D; Wang X; Chen Y; Gu T; Su W; Song N
Cancer Genet; 2020 Apr; 242():1-7. PubMed ID: 32036224
[TBL] [Abstract][Full Text] [Related]
15. Identification of specific modules and significant genes associated with colon cancer by weighted gene co‑expression network analysis.
Feng Y; Li Y; Li L; Wang X; Chen Z
Mol Med Rep; 2019 Jul; 20(1):693-700. PubMed ID: 31180534
[TBL] [Abstract][Full Text] [Related]
16. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
17. Identification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS).
Zhang W; Saif MW; Dutschman GE; Li X; Lam W; Bussom S; Jiang Z; Ye M; Chu E; Cheng YC
J Chromatogr A; 2010 Sep; 1217(37):5785-93. PubMed ID: 20696432
[TBL] [Abstract][Full Text] [Related]
18. A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery.
Ballesta A; Dulong S; Abbara C; Cohen B; Okyar A; Clairambault J; Levi F
PLoS Comput Biol; 2011 Sep; 7(9):e1002143. PubMed ID: 21931543
[TBL] [Abstract][Full Text] [Related]
19. Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy.
Liu SH; Cheng YC
J Ethnopharmacol; 2012 Apr; 140(3):614-23. PubMed ID: 22326673
[TBL] [Abstract][Full Text] [Related]
20. Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy.
Rockwell S; Grove TA; Liu Y; Cheng YC; Higgins SA; Booth CJ
Int J Radiat Biol; 2013 Jan; 89(1):16-25. PubMed ID: 22856538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
